Value in Health
Издатель: Elsevier · ISSN 1098-3015 · 75 статей
- Cost-effectiveness of insulin regimens and insulin types for adults with type 1 diabetes: a systematic review
- Cost-Effectiveness of Telisotuzumab Vedotin-tllv for Previously Treated High c-Met Protein-Overexpressing Nonsquamous Non-Small Cell Lung Cancer in the United States
- Sleep and fatigue/energy bolt-ons for the EQ-5D-3L and EQ-5D-5L: a systematic review
- Beyond Preference Heterogeneity: Toward Biobehavioral Stratification in Digital Neurorehabilitation
- Why Bayesian Nonparametric Models Should Be a First-Line Approach for Health State Valuations
- Individualized Prediction of Patient-Defined Treatment Success to Support Patient-Centered Clinical Decision Making
- Value-Based Care Contracting for Pharmacy Drugs: Opportunity for the United States
- Methods of economic evaluation need to reflect the reality of healthcare systems and the normative judgements that shape them
- Beyond the QALY: Putting Preferences to the Test in Health Technology Assessment
- Table of Contents
- Editorial Board
- Systematic Review of Health Economic Evaluations of Oral Nutritional Supplement Interventions in Older Adults: An ISPOR Special Interest Group Report
- Swimming in the Sea of Real-World Evidence Guidance: Why More Guidance Will Not Help Researchers Swim
- Swimming in the Sea of Real-World Evidence Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim
- Discounting Shortfall, Increasing Barriers: Pragmatic Objections to Discounting Shortfall in the NICE Severity Modifier
- A Competency Framework for Health Technology Assessment Expertise: Results From a Delphi Study
- Impact of Preventive Treatment on Healthcare Use: A Modeling Study of Statin Treatment
- Short Bowel Syndrome With Intestinal Failure: Healthcare Resource Utilization and Cost of Care in a Large US Claims Database
- Exploratory Economic Evaluation of a Genome Precision Report in Kidney and Liver Transplantation Care
- Impact of Drug Shortages on Medicare Part D Prescription Drugs Inflation Rebates
- Physician-Led Switching From Reference Biologics to Biosimilars: What Is the Effect on Selected Health-Related Outcomes and Costs for Patients With Inflammatory Bowel Disease in Germany?
- Modeling Systemic Lupus Erythematosus Treatment Cost-Effectiveness Based on a Novel Lupus Low Disease Activity State Treat-to-Target Approach
- Developing Best Practice for Analyzing Individual Patient Utility Data in Health Technology Assessment: A Modified Delphi Study
- Stakeholder Perspectives on Potential Open-Label Bias in Patient-Reported Outcome Results From Cancer Clinical Trials: Evidence From the IMPROvE Project
- Relationships Between Clinician-Confirmed Symptomatic Progression and Change in Patient-Reported Outcomes in Non-Small-Cell Lung Cancer
- Psychometric Properties of the Experimental and Modified EQ-HWB and EQ-HWB-9 in Patients with Anxiety and/or Depression in China
- Valuation of Child-Health-Related Quality of Life by Child Age and Problem Duration Using a Novel Method
- Are Preference-Weighted Cancer-Specific Measures More Sensitive Than Generic Measures? A Comparison of EQ-5D-5L, SF-6Dv2, FACT-8D, and QLU-C10D in Gastrointestinal Cancers
- Official Digital Health Technology Assessment Guidelines: An International Comparative Review and Analysis
- The Costs, Cost-Effectiveness, and Methods for Evaluating Clinical Registries: A Systematic Scoping Review